Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis

Ferroptosis is a new type of cell death discovered in recent years that distinguishes from apoptosis and necrosis, mainly caused by the imbalance between the production and degradation of lipid reactive oxygen species in cells. Although the mechanism of ferroptosis is not yet clear, the phenomenon o...

Full description

Bibliographic Details
Main Authors: Danni Yan, Zhenghong Wu, Xiaole Qi
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016423000385
_version_ 1797854307914088448
author Danni Yan
Zhenghong Wu
Xiaole Qi
author_facet Danni Yan
Zhenghong Wu
Xiaole Qi
author_sort Danni Yan
collection DOAJ
description Ferroptosis is a new type of cell death discovered in recent years that distinguishes from apoptosis and necrosis, mainly caused by the imbalance between the production and degradation of lipid reactive oxygen species in cells. Although the mechanism of ferroptosis is not yet clear, the phenomenon of ferroptosis has attracted widespread attention from researchers and has become a new hotspot in anti-tumor research. Studies have shown that ferroptosis is involved in the occurrence and development of a variety of diseases such as nervous system diseases, cardiovascular diseases and cancer. And inhibiting or inducing the occurrence of ferroptosis can effectively intervene in related diseases. At the same time, nanotechnology, by virtue of its distinct advantages, has been widely used in the development of nanodrug delivery systems. This review outlines current the advance on the intersection of ferroptosis and biomedical nanotechnology. In this review, the discovery and characteristics of ferroptosis, the mechanism of occurrence and the relationship with disease are summarized. More importantly, we summarized the strategies for inducing ferroptosis based on nanoparticulate drug delivery systems for cancer treatment.
first_indexed 2024-04-09T20:03:50Z
format Article
id doaj.art-04de53cc77c546c8bcdae4ac78560830
institution Directory Open Access Journal
issn 1319-0164
language English
last_indexed 2024-04-09T20:03:50Z
publishDate 2023-04-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj.art-04de53cc77c546c8bcdae4ac785608302023-04-02T06:12:15ZengElsevierSaudi Pharmaceutical Journal1319-01642023-04-01314554568Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosisDanni Yan0Zhenghong Wu1Xiaole Qi2Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, ChinaKey Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, China; Corresponding authors at: Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, China.Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, China; Industrial Technology Innovation Platform, Zhejiang Center for Safety Study of Drug Substances, Hangzhou 310018, China; Corresponding authors at: Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, China.Ferroptosis is a new type of cell death discovered in recent years that distinguishes from apoptosis and necrosis, mainly caused by the imbalance between the production and degradation of lipid reactive oxygen species in cells. Although the mechanism of ferroptosis is not yet clear, the phenomenon of ferroptosis has attracted widespread attention from researchers and has become a new hotspot in anti-tumor research. Studies have shown that ferroptosis is involved in the occurrence and development of a variety of diseases such as nervous system diseases, cardiovascular diseases and cancer. And inhibiting or inducing the occurrence of ferroptosis can effectively intervene in related diseases. At the same time, nanotechnology, by virtue of its distinct advantages, has been widely used in the development of nanodrug delivery systems. This review outlines current the advance on the intersection of ferroptosis and biomedical nanotechnology. In this review, the discovery and characteristics of ferroptosis, the mechanism of occurrence and the relationship with disease are summarized. More importantly, we summarized the strategies for inducing ferroptosis based on nanoparticulate drug delivery systems for cancer treatment.http://www.sciencedirect.com/science/article/pii/S1319016423000385FerroptosisMechanismDiseasesNanotherapeuticsCancer treatment
spellingShingle Danni Yan
Zhenghong Wu
Xiaole Qi
Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis
Saudi Pharmaceutical Journal
Ferroptosis
Mechanism
Diseases
Nanotherapeutics
Cancer treatment
title Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis
title_full Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis
title_fullStr Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis
title_full_unstemmed Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis
title_short Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis
title_sort ferroptosis related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis
topic Ferroptosis
Mechanism
Diseases
Nanotherapeutics
Cancer treatment
url http://www.sciencedirect.com/science/article/pii/S1319016423000385
work_keys_str_mv AT danniyan ferroptosisrelatedmetabolicmechanismandnanoparticulateanticancerdrugdeliverysystemsbasedonferroptosis
AT zhenghongwu ferroptosisrelatedmetabolicmechanismandnanoparticulateanticancerdrugdeliverysystemsbasedonferroptosis
AT xiaoleqi ferroptosisrelatedmetabolicmechanismandnanoparticulateanticancerdrugdeliverysystemsbasedonferroptosis